# SNIPER Next Autonomous Mission

Mode: `PR_DRAFT_READY_WITH_NO_SAFE_NEXT_ACTION`

Previous gate executed: `phase5_research_feature_family_ablation_blocker_decomposition_gate`

Previous family: `feature_family_ablation_blocker_decomposition`

Previous candidate: `diagnostic_only_no_candidate`

Previous result: `FEATURE_FAMILY_ABLATION_COMPLETE_NO_HIGH_MEDIUM_EXECUTABLE_FAMILY`

Current next gate: `none_high_medium_executable`

Final classification: `FULL_FREEZE_AFTER_REAUDIT_AND_AGENDA_EXHAUSTED`

Autonomous can continue: `false`

Human decision required: `true`

## Rationale

The checkpoint continuation mission executed H03, H04 and H05 after the prior
H02 falsification.

- H03 `cvar_constrained_meta_sizing` produced nonzero research/sandbox exposure
  and research CVaR within bound, but stayed `PARTIAL/correct` because min
  Sharpe and sensitivity were unstable.
- H04 `regime_specific_meta_disagreement` produced nonzero research/sandbox
  exposure and research CVaR within bound, but stayed `PARTIAL/correct` because
  exposure was sparse and min Sharpe/sensitivity were unstable.
- H05 `feature_family_ablation_blocker_decomposition` completed diagnostic-only
  decomposition and found no remaining HIGH/MEDIUM executable in-repo research
  family.

H06 `unlock_shadow_feature_ablation` remains LOW priority and depends on absent
or shadow-only unlock artifacts. It is not an autonomous next gate for this
mission.

## Next Mission

No safe HIGH/MEDIUM in-repo autonomous gate remains in the current agenda.

The correct next action is to update the existing draft PR and request human
review as governance/reproducibility evidence, not operational readiness.

## Stop Conditions Satisfied

- Agenda expansion was executed after freeze.
- H01-H04 were executed and failed, were falsified or remained only partial.
- H05 diagnostic completed.
- No HIGH/MEDIUM executable research-only family remains.
- Continuing would require a new agenda expansion with materially new evidence,
  external/shadow unlock artifacts, or a specification/product decision.

## Restrictions

- No official promotion.
- No paper readiness.
- No A3/A4 reopening.
- No threshold relaxation.
- No fabricated artifacts.
- No realized variable as ex-ante rule.
- No merge.
